Probucol and multivitamins in the prevention of restenosis after coronary angioplasty

New England Journal of Medicine

Volumn 337, Issue 26, 1997, Pages 1919-

  Lisi, Donna M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; PROBUCOL;

CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MALE; NOTE; RECURRENT DISEASE; TORSADE DES POINTES; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIOXIDANTS; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; PROBUCOL; RECURRENCE; TORSADES DE POINTES;

EID: 0031586647     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Klein L. QT-interval prolongation produced by probucol. Arch intern Med 1981;141:1102-3.
2. The Pink Sheet. Washington, D.C.: FDC Reports, October 9, 1995.
3. Reinoehl J, Frankovich D, Machado C, et al. Probucol-associated tachyarrhythmic events and QT prolongation: importance of gender. Am Heart J 1996;131:1184-91.